Inovio Pharmaceuticals is based in Philadelphia, Pennsylvania. It has raised $250M in total funding. Backed by NIH, Gates Foundation, DARPA.
Inovio Pharmaceuticals funding overview
Inovio Pharmaceuticals is based in Philadelphia, Pennsylvania. Inovio Pharmaceuticals has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Investors on record include NIH, Gates Foundation, DARPA, CEPI. 4 distinct backers are named across the disclosed rounds.
Inovio Pharmaceuticals at a glance
Total raised
$250M
Headquarters
Philadelphia, Pennsylvania
Notable investors
NIH, Gates Foundation, DARPA, CEPI
Frequently asked about Inovio Pharmaceuticals funding
How much has Inovio Pharmaceuticals raised?
Inovio Pharmaceuticals has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Inovio Pharmaceuticals?
NIH, Gates Foundation, DARPA, CEPI are named among the investors backing Inovio Pharmaceuticals.
What was the latest Inovio Pharmaceuticals funding round?
No round stage has been disclosed for Inovio Pharmaceuticals.
Where is Inovio Pharmaceuticals based?
Inovio Pharmaceuticals is based in Philadelphia, Pennsylvania.
Totals shown for Inovio Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.
